Dose response characteristics for the hyperglycemic, hyperlactemic, hypotensive and hypocalcemic actions of amylin and calcitonin gene-related peptide-I (CGRPα) in the fasted, anaesthetized rat

This publication has 26 references indexed in Scilit:

• Hyperamylinemia, hyperinsulinemia, and insulin resistance in genetically obese LA/N-cp rats.
  Hypertension, 1992
• Effects of ciglitazone on endogenous plasma islet amyloid polypeptide and insulin sensitivity in obese-diabetic viable yellow mice
  Life Sciences, 1991
• ^8–37h‐CGRP antagonizes actions of amylin on carbohydrate metabolism in vitro and in vivo
  FEBS Letters, 1991
• Amylin injection causes elevated plasma lactate and glucose in the rat
  FEBS Letters, 1991
• Amylin secretion from the perfused pancreas: Dissociation from insulin and abnormal elevation in insulin-resistant diabetic rats
  Biochemical and Biophysical Research Communications, 1991
• Selective antagonism of calcitonin-induced osteoclastic quiescence (Q effect) by human calcitonin gene-related peptide-(Val8Phe37)
  Biochemical and Biophysical Research Communications, 1991
• Amylin increases cyclic AMP formation in L6 myocytes through calcitonin gene-related peptide receptors
  Biochemical and Biophysical Research Communications, 1991
• In vivo insulin resistance induced by amylin primarily through inhibition of insulin-stimulated glycogen synthesis in skeletal muscle
  Diabetes, 1991
• The amylin superfamily: A novel grouping of biologically active polypeptides related to the insulin A-chain
  Progress in Growth Factor Research, 1989
• Islet amyloid polypeptide: Identification and chromosomal localization of the human gene
  FEBS Letters, 1988